GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Clinical Kidney Journal, Oxford University Press (OUP), Vol. 15, No. 3 ( 2022-02-22), p. 372-387
    Abstract: Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of CKD is relatively young and uptake by the public, physicians and health authorities is not widespread. Physicians still confuse CKD with chronic kidney insufficiency or failure. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. Thus health authorities may consider CKD a non-issue: very few persons eventually need KRT and, for those in whom kidneys fail, the problem is ‘solved’ by dialysis or kidney transplantation. However, KRT is the tip of the iceberg in the burden of CKD. The main burden of CKD is accelerated ageing and premature death. The cut-off points for kidney function and kidney damage indexes that define CKD also mark an increased risk for all-cause premature death. CKD is the most prevalent risk factor for lethal coronavirus disease 2019 (COVID-19) and the factor that most increases the risk of death in COVID-19, after old age. Men and women undergoing KRT still have an annual mortality that is 10- to 100-fold higher than similar-age peers, and life expectancy is shortened by ~40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth greatest global cause of death by 2040 and the second greatest cause of death in Spain before the end of the century, a time when one in four Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded Centres for Biomedical Research (CIBER) network structure in Spain. Realizing the underestimation of the CKD burden of disease by health authorities, the Decade of the Kidney initiative for 2020–2030 was launched by the American Association of Kidney Patients and the European Kidney Health Alliance. Leading Spanish kidney researchers grouped in the kidney collaborative research network Red de Investigación Renal have now applied for the Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) call for collaborative research in Spain with the support of the Spanish Society of Nephrology, Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true.
    Type of Medium: Online Resource
    ISSN: 2048-8505 , 2048-8513
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2022
    detail.hit.zdb_id: 2656786-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Elsevier BV ; 2021
    In:  FMC - Formación Médica Continuada en Atención Primaria Vol. 28, No. 4 ( 2021-04), p. 210-214
    In: FMC - Formación Médica Continuada en Atención Primaria, Elsevier BV, Vol. 28, No. 4 ( 2021-04), p. 210-214
    Type of Medium: Online Resource
    ISSN: 1134-2072
    Language: Spanish
    Publisher: Elsevier BV
    Publication Date: 2021
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    Online Resource
    Online Resource
    Informa UK Limited ; 2018
    In:  International Journal of Nephrology and Renovascular Disease Vol. Volume 11 ( 2018-01), p. 41-51
    In: International Journal of Nephrology and Renovascular Disease, Informa UK Limited, Vol. Volume 11 ( 2018-01), p. 41-51
    Type of Medium: Online Resource
    ISSN: 1178-7058
    Language: English
    Publisher: Informa UK Limited
    Publication Date: 2018
    detail.hit.zdb_id: 2508160-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Hypertension, Ovid Technologies (Wolters Kluwer Health), Vol. 60, No. suppl_1 ( 2012-09)
    Abstract: Renal function and albuminuria predict CV disease in general population, but their predictive value in resistant hypertension (RH) is rather unknown. Aim: to determine the ability of renal parameters to predict adverse CV outcomes in RH patients. Methods: One hundred thirty-three (59% males, aged 61yr) RH pts. (BP ≥140/90 mmHg despite treated with ≥3 antihypertensive drugs) were evaluated. Mean follow-up: 88±5 months. Primary composite end-point: first occurrence of a CV event (nonfatal myocardial infarction, nonfatal stroke, new-onset heart failure, coronary or peripheral by-pass) or CV death. Renal function was assessed by serum creatinine, creatinine clearance (CrCL) and urine albumin/creatinine ratio (UACR). Microalbuminuria (MAB) was defined as UACR 〉 30mg/g. Results: Twenty-two subjects (16.5%) reached the primary end-point. After adjustments for previous CV disease, systolic BP both at baseline and during follow-up and CrCl, high UACR during follow-up was significantly associated with a worse CV outcome (Table). More patients who had a CV event developed MAB at follow-up (28% vs. 6%), whereas the proportion with MAB regression in this group was lower (11% vs. 19%); p=0.005. Although renal function was also associated with outcome in unadjusted analyses, the significance was lost after baseline risk and BP adjustment. Conclusion: in patients with resistant hypertension, microalbuminuria at follow-up but not at baseline independently predicts CV outcomes. * adjusted for SBP both at baseline and during follow-up and previous CV disease ** adjusted for the aforementioned confounders plus CrCl both at baseline and at follow-up; UACR tested after log transformation.
    Type of Medium: Online Resource
    ISSN: 0194-911X , 1524-4563
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2012
    detail.hit.zdb_id: 2094210-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 36, No. Supplement_1 ( 2021-05-29)
    Abstract: Acute renal failure (AKI) associated to rhabdomyolysis conditions a worse prognosis in short-term, its implication in the long-term renal function has been less evaluated. Method Retrospective analysis of patients diagnosed with rhabdomyolysis defined by creatinine kinase & gt; 5000 IU/L between 2015-2019. Basal and 12-month renal function was evaluated. AKI was classified as either non-severe (AKI-KDIGO 1/2) or severe (AKI-KDIGO 3). Results Eighty-seven patients were included, 25 (28.74%) had some degree of chronic kidney disease (CKD) on admission. 56 (64.37%) had AKI on admission, 17 of which were severe (6 required hemodialysis). The patients with AKI had more cardiovascular disease (CVD) and worse analytical parameters on admission (table). Patients with severe AKI showed no difference in CVD from those with non-severe AKI but were younger and had more hyperkalemia. There were no significant differences between patients with severe AKI who required hemodialysis and those who did not. Inpatient mortality was 8%, higher in patients with AKI but without differences according to severity. In 45 patients kidney function was available 12 months after the episode, loss of eGF was -4.90 ± 14.35 ml/min-1.73m2 (p=0.007). There was no difference between patients who developed AKI and those who did not (-4.10 ± 14.4 vs. -5.39 ± 14.57 ml/min-1.73m2; p=0.67), nor between non-severe and severe AKI (-5.50 ± 14.76 vs. -5.12 ± 15.08ml/min-1.73m2; p=0.98). Of the 33 patients without previous CKD, 5 developed CKD, with greater decrease in eGF than those who did not (-22.69 ± 6.04 vs. -2.63 ± 13.92 ml/min-1.73m2; p=0.003). Female sex (60% vs. 12%; p=0.031) and previous basal eGF (72.22 ± 4.37 vs. 95.6±19.97 ml/min-1.72m2; p=0.016) were related to this deterioration. Conclusion After an episode of rhabdomyolysis, the loss of eGF is similar in patients who develop AKI compared to those who do not.
    Type of Medium: Online Resource
    ISSN: 0931-0509 , 1460-2385
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2021
    detail.hit.zdb_id: 1465709-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Journal of Hypertension, Ovid Technologies (Wolters Kluwer Health), Vol. 34, No. 9 ( 2016-09), p. 1863-1871
    Type of Medium: Online Resource
    ISSN: 0263-6352
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2016
    detail.hit.zdb_id: 2017684-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 35, No. Supplement_3 ( 2020-06-01)
    Abstract: Between the 2-8% of pregnancies suffer preeclampsia (PE). In the literature, there have been reported cases of glomerulopathy debuted by pregnancy (GDP) which are initially missdiagnosed as PE. These cases are unusual and not well-defined. We aimed to evaluate clinical and analytical factors that allow us to suspect that a PE masks a GDP. Method Retrospective study that included pregnant patients with a postpartum histological diagnosis of glomerulopathy who had been missdiagnosed as PE during pregnancy. We compared them with patients who suffered PE with full recovery after childbirth. We evaluate demographic variables of pregnant women and newborns, clinical variables related to pregnancy and childbirth, blood pressure (BP) and analytical variables before pregnancy and postpartum (serum creatinine (sCrea), estimated glomerular filtration rate by CKD-EPI equation (eGFR), serum uric acid (sUA), ratio of urine protein to creatinine (UPCR)). Results Thirty patients were included in the study ,10 patients with a postpartum histological diagnosis of glomerulopathy who had been diagnosed as PE during the pregnancy and 20 patients with a diagnosis of PE without GDP, baseline characteristics are described in attached table. Glomerulopathy was diagnosis through renal biopsy, main indication of renal biopsy was the persistence of proteinuria and/or sediment abnormalities after 4 months of childbirth. The diagnoses were: IgA nephropathy (3, 33.3%), focal and segmental hyalinosis (2, 22.2%), X-linked Alport syndrome (2, 22.2%), diabetic nephropathy (1, 11.1%), lupus nephritis (1, 11.1%) and chronic interstitial nephropathy (1, 11.1%). Pregnant women with GDP showed higher prevalence of smoking habit and major value of sCrea and sUA (figure). Regarding to pregnancy factors, patients with GDP had significant higher prevalence of primiparous gestation (100% vs 40%, p=0.002), twin gestation (20% vs 0%, p=0.03), premature newborn (50% vs 15%, p=0.01) and higher weight gain during pregnancy (13.9±5.8 vs 9.5±3.6 kg, p=0.01). Furthermore, in the postpartum data we objected a higher value of systolic/diastolic BP (145.6±10.3 / 89.4±12.1 vs 128.5±10.0 / 80.0±6.3 mmHg, p & lt;0.05), sCrea (0.83±0.3 vs 0.54±0.2 mg/dl, p=0.02), sUA (5.8±1.3 vs 3.4±0.8 mg/dl, p & lt;0.001) and UPCR (3046 [613-4179] vs 802 [281-948] mg/g, p=0.05) in patient with NPD. Conclusion Our results suggest that clinical and analytical variables in pregnancy and post-partum allow clinicians suspect a glomerulopathy in the setting of PE. Patients diagnosed as PE who develop GDP had higher prevalence of smoking habit, primiparous gestation, twin gestation and premature newborns. In addition, they also have higher weight gain during pregnancy, worse renal function and major sUA before pregnancy and after childbirth, and major UPCR and BP after childbirth; compared with patients with PE and full recovery after childbirth.
    Type of Medium: Online Resource
    ISSN: 0931-0509 , 1460-2385
    Language: English
    Publisher: Oxford University Press (OUP)
    Publication Date: 2020
    detail.hit.zdb_id: 1465709-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 8
    Online Resource
    Online Resource
    Elsevier BV ; 2013
    In:  Medicina Clínica Vol. 140, No. 6 ( 2013-3), p. 263-265
    In: Medicina Clínica, Elsevier BV, Vol. 140, No. 6 ( 2013-3), p. 263-265
    Type of Medium: Online Resource
    ISSN: 0025-7753
    Language: Spanish
    Publisher: Elsevier BV
    Publication Date: 2013
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 9
    In: Hypertension, Ovid Technologies (Wolters Kluwer Health), Vol. 76, No. Suppl_1 ( 2020-09)
    Abstract: Objective: to analyze AS before and 1 month (m) after bariatric surgery (BS), and search for pathophysiological mechanisms of changes (Δ). Methods: Forty-seven MO (72% women, 43% hypertensives, age 42.7±9.4 yr, BMI 42.2±5.4 Kg/m 2 , waist circumference 132.4±11.7 cm) were evaluated before and 1m after BS, with AS assessed by pulse-wave velocity (PWV), augmentation index at 75 beats/minute (AIx@75) and pulse pressure (PP) using a Mobile-O-Graph® device. 24h-ambulatory blood pressure (BP), RAAS components and several adipokines and inflammatory markers were also analyzed. Results: at 1m body weight (-13.6±4.32 Kg) and waist circumference (-9.2±5.3 cm) decreased (p 〈 0.001). There were also significant Δ in BP, RAAS components and adipokines and inflammatory biomarkers (Table). Correlations were also explored. There was no correlation between Δ of any marker of AS and anthropometric changes nor with Δ of adipokines or inflammatory markers. Δ 24h-PP correlated with Δ 24h-systolic BP (coef. P. = 0.749; p 〈 0.001) and with Δ of plasma renin activity (rho = -0.299; p = 0.049). Δ 24h-PWV correlated with Δ 24h-SBP (coef. P. = 0.587; p 〈 0.001), with Δ 24h-DBP (coef. P. = 0.503; p 〈 0.001) and with Δ ACE/ACE2 (coef. P. = -0.474; p =0.002). Δ AIx@75 correlated with Δ ACE (coef. P. = 0.316; p = 0.041). Conclusions: there is a decrease in AS one month after BS in obese patients. These changes correlated with Δ in both BP and the renin-angiotensin aldosterone system. ( * ) Data shown as median [interquartile range]
    Type of Medium: Online Resource
    ISSN: 0194-911X , 1524-4563
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2020
    detail.hit.zdb_id: 2094210-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 10
    In: Hypertension, Ovid Technologies (Wolters Kluwer Health), Vol. 66, No. suppl_1 ( 2015-09)
    Abstract: Aim: To compare the efficacy and safety between two therapeutic strategies to reduce 24h-SBP in patients with resistant hypertension: renal denervation or the addition of spironolactone. Methods: Twenty-one patients with office-SBP ≥150 mmHg and 24h-SBP≥140 mmHg despite receiving ≥3 full-dose antihipertensive drugs, one a diuretic, but without aldosterone antagonists, were randomized to renal denervation (by Simplicity®) or to spironolactone (25-50 mg), as add-on therapy. Changes in both office- (3 averaged readings) and 24h- BP (by Spacelabs®-90207) were evaluated at 6 months. Comparisons between treatment groups were performed using analysis of variance adjusted by age, gender and baseline values. Results: mean age was 62.7 ± 7.6 yr; men: 61.9% (13 of 21); diabetes: 47,6% (10 of 21). Mean BMI: 32.3 ± 6.1 Kg/m 2 . Duration of hypertension: 13.4 ± 7.2 yr. Number of antihypertensive drugs: 4,1 ± 0,7. Mean office-BP: 167,5 ± 20,1 / 91,7 ± 12,4 mmHg. Mean 24h-BP: 151,8 ± 9,1 / 81,7 ± 8,4 mmHg. Baseline characteristics were not different between groups (p=NS for all). Comparison between groups of main changes over time is shown in Table. Reduction of 24h-SBP was higher in the spironolactone group after adjusting by age, sex and baseline 24h-SBP (p=0.016). Reduction of eGFR was higher in the spironolactone group after adjusting by baseline eGFR (p=0.033). Conclusions: 1) As compared to renal denervation, spironolactone was more effective to reduce 24h-SBP after 6 months in patients with resistant hypertension. These differences were not significant as regards office-BP. 2) Spironolactone add-on treatment significantly decreased eGFR as compared to renal denervation treatment.
    Type of Medium: Online Resource
    ISSN: 0194-911X , 1524-4563
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2015
    detail.hit.zdb_id: 2094210-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...